NCT01768637View on ClinicalTrials.gov

Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Chronic Kidney Disease
Interventions
DRUG

Aspirin

Aspirin 81 mg by mouth daily

DRUG

Clopidogrel

Clopidogrel 75 mg by mouth once daily

Trial Locations (1)

75390-8856

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Texas Southwestern Medical Center

OTHER

NCT01768637 - Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study | Biotech Hunter | Biotech Hunter